# Accendra Health Inc: filings

ACH · NYSE · CIK 75252 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ach.md) · [Financials](/companies/ach/financials.md) · [Filings](/companies/ach/filings.md) · [Insiders](/companies/ach/insiders.md)

## Reports and events: 333 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 1370, 8-K 232, SC 13G/A 70, 10-Q 53, 3 48, 4/A 37, 144 32, UPLOAD 22, CORRESP 21, DEF 14A 19, DEFA14A 19, 10-K 18, SC 13G 14, 5 11, SCHEDULE 13G/A 11, 8-K/A 10, S-8 10, 11-K 8, SD 8, ARS 7, 424B2 3, S-8 POS 3, SCHEDULE 13G 3, EFFECT 2, S-3 2, S-3ASR 2, 15-15D 1, 3/A 1, 424B3 1, 424B5 1, 8-A12B 1, FWP 1, NT 10-K 1, PRE 14A 1, SCHEDULE 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-30 | 16:50 ET | [8-K](/filings/0001104659-26-120716.md) | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-120716 |
| 2026-10-29 | 16:15 ET | [DEF 14A](/filings/0001104659-26-120208.md) | Proxy statement, period 2026-12-01 | 0001104659-26-120208 |
| 2026-10-09 | 16:10 ET | [8-K](/filings/0001104659-26-115043.md) | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-115043 |
| 2026-09-28 | 17:06 ET | [8-K/A](/filings/0001104659-26-111408.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-26-111408 |
| 2026-09-17 | 06:35 ET | [8-K](/filings/0001104659-26-108405.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-108405 |
| 2026-08-17 | 06:42 ET | [8-K](/filings/0001104659-26-097517.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-097517 |
| 2026-08-10 | 16:15 ET | [8-K](/filings/0001104659-26-093381.md) | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-093381 |
| 2026-08-10 | 11:15 ET | [10-Q](/filings/0001104659-26-093177.md) | Quarterly report, period 2026-06-30 | 0001104659-26-093177 |
| 2026-08-10 | 06:50 ET | [8-K](/filings/0001104659-26-092999.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-092999 |
| 2026-08-10 | 06:36 ET | [8-K](/filings/0001104659-26-092973.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-092973 |
| 2026-06-25 | 16:15 ET | [8-K](/filings/0001193125-26-282808.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-282808 |
| 2026-06-15 | 16:15 ET | [8-K](/filings/0001193125-26-271115.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-271115 |
| 2026-05-22 | 16:08 ET | [8-K](/filings/0001193125-26-236869.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-236869 |
| 2026-05-15 | 08:30 ET | [8-K](/filings/0001104659-26-061888.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001104659-26-061888 |
| 2026-05-11 | 11:59 ET | [10-Q](/filings/0001104659-26-058465.md) | Quarterly report, period 2026-03-31 | 0001104659-26-058465 |
| 2026-05-11 | 06:50 ET | [8-K](/filings/0001193125-26-215654.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-215654 |
| 2026-05-11 | 06:35 ET | [8-K](/filings/0001104659-26-058226.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-058226 |
| 2026-04-02 | 06:25 ET | [DEF 14A](/filings/0001104659-26-038823.md) | Proxy statement, period 2026-05-14 | 0001104659-26-038823 |
| 2026-02-20 | 16:19 ET | [10-K](/filings/0001104659-26-018169.md) | Annual report, period 2025-12-31 | 0001104659-26-018169 |
| 2026-02-19 | 16:10 ET | [8-K](/filings/0001104659-26-017541.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-017541 |
| 2026-01-05 | 16:05 ET | [8-K/A](/filings/0001104659-26-000614.md) | 9.01 Financial statements and exhibits | 0001104659-26-000614 |
| 2025-12-31 | 16:15 ET | [8-K](/filings/0001193125-25-338325.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-338325 |
| 2025-12-18 | 16:18 ET | [8-K](/filings/0001104659-25-122553.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-122553 |
| 2025-12-08 | 06:45 ET | [8-K](/filings/0001193125-25-310528.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure | 0001193125-25-310528 |
| 2025-12-02 | 07:16 ET | [8-K](/filings/0001193125-25-304500.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-304500 |
| 2025-11-14 | 16:15 ET | [SCHEDULE 13D](/filings/0001193125-25-282986.md) | Ownership report, active investor | 0001193125-25-282986 |
| 2025-10-31 | 17:35 ET | [10-Q](/filings/0001104659-25-104506.md) | Quarterly report, period 2025-09-30 | 0001104659-25-104506 |
| 2025-10-30 | 16:10 ET | [8-K](/filings/0001104659-25-104379.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-104379 |
| 2025-10-07 | 16:48 ET | [8-K](/filings/0001193125-25-233577.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-233577 |
| 2025-09-19 | 06:30 ET | [8-K](/filings/0001193125-25-208137.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-208137 |
| 2025-08-11 | 16:40 ET | [10-Q](/filings/0001558370-25-011059.md) | Quarterly report, period 2025-06-30 | 0001558370-25-011059 |
| 2025-08-11 | 06:41 ET | [8-K](/filings/0001193125-25-177426.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-177426 |
| 2025-06-06 | 16:30 ET | [8-K](/filings/0001193125-25-137107.md) | 2.04 Item not in the standard list | 0001193125-25-137107 |
| 2025-06-05 | 09:12 ET | [8-K](/filings/0001193125-25-135378.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-135378 |
| 2025-05-16 | 08:30 ET | [8-K](/filings/0001558370-25-007927.md) | 5.07 Shareholder vote results | 0001558370-25-007927 |
| 2025-05-08 | 16:05 ET | [10-Q](/filings/0001558370-25-006964.md) | Quarterly report, period 2025-03-31 | 0001558370-25-006964 |
| 2025-05-08 | 06:35 ET | [8-K](/filings/0001558370-25-006844.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-006844 |
| 2025-04-04 | 17:24 ET | [8-K](/filings/0001193125-25-073544.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-25-073544 |
| 2025-04-04 | 06:05 ET | [DEF 14A](/filings/0001193125-25-072752.md) | Proxy statement, period 2025-05-15 | 0001193125-25-072752 |
| 2025-04-02 | 17:30 ET | [8-K](/filings/0001193125-25-071448.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-071448 |
| 2025-03-26 | 16:49 ET | [8-K](/filings/0001193125-25-064131.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-064131 |
| 2025-03-20 | 06:51 ET | [8-K](/filings/0001193125-25-058292.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-058292 |
| 2025-02-28 | 16:05 ET | [10-K](/filings/0001558370-25-001940.md) | Annual report, period 2024-12-31 | 0001558370-25-001940 |
| 2025-02-28 | 06:35 ET | [8-K](/filings/0001558370-25-001879.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-001879 |
| 2025-02-03 | 06:49 ET | [8-K](/filings/0001193125-25-018849.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-018849 |
| 2024-11-05 | 16:05 ET | [8-K](/filings/0001558370-24-014426.md) | 5.02 Departure or appointment of officers or directors | 0001558370-24-014426 |
| 2024-11-04 | 16:06 ET | [10-Q](/filings/0001558370-24-014255.md) | Quarterly report, period 2024-09-30 | 0001558370-24-014255 |
| 2024-11-04 | 06:35 ET | [8-K](/filings/0001558370-24-014177.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-014177 |
| 2024-10-22 | 16:16 ET | [8-K](/filings/0001193125-24-241069.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-24-241069 |
| 2024-10-15 | 07:01 ET | [8-K](/filings/0001193125-24-237188.md) | 8.01 Other events | 0001193125-24-237188 |

Page 1 of 7. [Older](/companies/ach/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 17:00 ET. No prices; not investment advice.